NEWS

Click the link below to read the article highlighting Galibra Neuroscience, as it appears on the cover of the Life Science Review Journal.  In the article Galibra Neuroscience founders Drs. Henry Lee and Alexander Rotenberg, share their plans to use gene therapy to treat GABA Disorders.

https://www.lifesciencesreview.com/galibra-neuroscience 

We are anxiously awaiting toxicology and bio-distribution testing that will bring Galibra one step closer to completing the preclinical research phase of the FDA approval process before beginning human clinical trials.

We are grateful to Drs. Lee and Rotenberg for their resolve to bring a treatment to the SSADH Community.